Morgan Stanley’s BioVie BIVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.11K | Buy |
553
+67
| +14% | +$619 | ﹤0.01% | 7026 |
|
2025
Q1 | $4.77K | Sell |
486
-2,027
| -81% | -$19.9K | ﹤0.01% | 7005 |
|
2024
Q4 | $50.3K | Buy |
2,513
+2,237
| +811% | +$44.7K | ﹤0.01% | 6287 |
|
2024
Q3 | $3.31K | Buy |
276
+152
| +123% | +$1.83K | ﹤0.01% | 7020 |
|
2024
Q2 | $4.95K | Sell |
124
-122
| -50% | -$4.87K | ﹤0.01% | 6854 |
|
2024
Q1 | $13K | Sell |
246
-1,415
| -85% | -$74.8K | ﹤0.01% | 6605 |
|
2023
Q4 | $209K | Buy |
1,661
+1,108
| +200% | +$140K | ﹤0.01% | 5929 |
|
2023
Q3 | $189K | Buy |
553
+185
| +50% | +$63.1K | ﹤0.01% | 5605 |
|
2023
Q2 | $159K | Buy |
368
+94
| +34% | +$40.5K | ﹤0.01% | 5740 |
|
2023
Q1 | $221K | Buy |
274
+51
| +23% | +$41.1K | ﹤0.01% | 5669 |
|
2022
Q4 | $174K | Buy |
223
+202
| +962% | +$157K | ﹤0.01% | 5724 |
|
2022
Q3 | $5K | Buy |
21
+6
| +40% | +$1.43K | ﹤0.01% | 7241 |
|
2022
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 7569 |
|
2022
Q1 | $7K | Hold |
15
| – | – | ﹤0.01% | 7492 |
|
2021
Q4 | $7K | Buy |
15
+14
| +1,400% | +$6.53K | ﹤0.01% | 7561 |
|
2021
Q3 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 7753 |
|
2021
Q2 | – | Hold |
0
| – | -$1K | – | 7588 |
|
2021
Q1 | – | Sell |
-8
| Closed | -$14K | – | 7325 |
|
2020
Q4 | $14K | Hold |
8
| – | – | ﹤0.01% | 6542 |
|
2020
Q3 | $8K | Buy |
+8
| New | +$8K | ﹤0.01% | 6324 |
|